Primary care providers need more education when it comes to PrEP, not only for them, but also for patients, who often think they need to see a specialist just to take this preventative medicine.
Activists working on human rights discuss the challenges of achieving an end to the HIV epidemic.
World Health Organization Updates Guidance on Dolutegravir After Reassuring Data Regarding Safety in Early Pregnancy
New study results leave many experts feeling they went too far in their concerns over birth defect risks associated with the drug.
Having Fallen Out of Care, Most Gay and Bisexual Men With Detectable HIV Viral Loads Were Successfully Reconnected, Study Finds
The study enrolled more than a thousand people in four U.S. cities: Atlanta, Baltimore, Birmingham, and Boston.
Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
This week, a study finds that injectable cabotegravir, an investigational integrase inhibitor, is well tolerated and shows promise as pre-exposure prophylaxis (PrEP).
These restrictions have no proven public-health benefit -- and can, in fact, shroud nations in a false sense of assurance that such bans, and not sound health policy, will keep HIV in their countries.
Research on Two Supplements Addresses HIV-Driven Inflammation in the Gut -- A Blog Entry by Jeannie Wraight
"Gastrointestinal (GI) health is proving to be a vital, though often ignored, component of HIV infection."
People living with HIV in North America who receive antiretroviral therapy have improving -- near normal, in fact -- life expectancy, according to new data presented at IAS 2013.
Investigators from the NA-ACCORD presented the results of their analys...
Roughly one out of every 13 gay men in a recent study had detectable HIV in their semen but an undetectable viral load in their bloodstream.